Prelude Capital Management’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

Prelude Capital Management’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-51,000	Closed	-$2.01M	–	1494
2023 Q2	$2.01M	Buy	+51,000	New	+$1.8M	0.13%	200

Prelude Capital Management's ISEE Position: Q3 2023 in Review

Prelude Capital Management sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 324,802 shares — an estimated $12.8M sold.

Prelude Capital Management first reported a position in ISEE in Q2 2014 and held it in 8 quarters. The position peaked at $12.8M in Q2 2023. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

Prelude Capital Management reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Prelude Capital Management sold 324,802 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $12.8M.
Prelude Capital Management first reported a position in IVERIC bio, Inc. Common Stock in Q2 2014 and held it in 8 quarters.
Prelude Capital Management's IVERIC bio, Inc. Common Stock position peaked at $12.8M in Q2 2023.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on Prelude Capital Management's 13F filing for Q3 2023, filed 14 Nov 2023.